Clorox Beheer
Beheer criteriumcontroles 4/4
Clorox's CEO is Linda Rendle, appointed in Sep 2020, has a tenure of 4.17 years. total yearly compensation is $12.69M, comprised of 9.6% salary and 90.4% bonuses, including company stock and options. directly owns 0.014% of the company’s shares, worth $2.82M. The average tenure of the management team and the board of directors is 4.2 years and 7 years respectively.
Belangrijke informatie
Linda Rendle
Algemeen directeur
US$12.7m
Totale compensatie
| Percentage CEO-salaris | 9.6% |
| Dienstverband CEO | 4.2yrs |
| Eigendom CEO | 0.01% |
| Management gemiddelde ambtstermijn | 4.2yrs |
| Gemiddelde ambtstermijn bestuur | 7yrs |
Recente managementupdates
Recent updates
An Intrinsic Calculation For The Clorox Company (NYSE:CLX) Suggests It's 40% Undervalued
Oct 07
Why We're Not Concerned About The Clorox Company's (NYSE:CLX) Share Price
Sep 21Clorox: If You Need FMCG Player In A Portfolio - Look Elsewhere
Sep 15Clorox (NYSE:CLX) Will Pay A Larger Dividend Than Last Year At $1.22
Aug 03Here's What To Make Of Clorox's (NYSE:CLX) Decelerating Rates Of Return
Jul 29Clorox: Stellar Delivery But Valuation Compression Has Some Distance To Go
Jul 29Clorox: Questionable Growth Target Puts Me On The Sidelines
Jul 17Clorox: Improving Outlook, Good Dividend Yield And Discounted Valuation
Jun 28Is Clorox (NYSE:CLX) A Risky Investment?
May 25We Like The Quality Of Clorox's (NYSE:CLX) Earnings
May 07Clorox (NYSE:CLX) Could Be At Risk Of Shrinking As A Company
Apr 26Colgate-Palmolive: Improved Financials To Navigate Headwinds (Rating Upgrade)
Apr 21Is There An Opportunity With The Clorox Company's (NYSE:CLX) 31% Undervaluation?
Apr 10Is Clorox (NYSE:CLX) Using Too Much Debt?
Feb 09Clorox: Relatively Overvalued And Headwinds Put Dividend At Risk
Feb 08The Clorox Company's (NYSE:CLX) Popularity With Investors Is Under Threat From Overpricing
Jan 25Is The Clorox Company (NYSE:CLX) Trading At A 27% Discount?
Jan 07Clorox: Not Wiped Out By Cyber Attack, Earnings And Revenue Need Cleaning Up
Jan 03Be Wary Of Clorox (NYSE:CLX) And Its Returns On Capital
Dec 18Clorox: One Of The Best Household Product Portfolios
Dec 01The Clorox Company's (NYSE:CLX) CEO Might Not Expect Shareholders To Be So Generous This Year
Nov 09Clorox: Undervalued But Too Many Red Flags
Oct 28Clorox (NYSE:CLX) Seems To Use Debt Quite Sensibly
Oct 16Clorox: Cyberattack Compounds Existing Challenges
Oct 10Clorox's (NYSE:CLX) Shareholders Will Receive A Bigger Dividend Than Last Year
Oct 01Clorox: Still Struggling
Sep 25Are Investors Undervaluing The Clorox Company (NYSE:CLX) By 35%?
Sep 21Returns On Capital Signal Difficult Times Ahead For Clorox (NYSE:CLX)
Sep 03The Clorox Company: The Necessary Clean-Up Has Only Begun
Aug 30Despite Earnings Rally, Expectations On Clorox Are Low
Aug 15Clorox's (NYSE:CLX) Upcoming Dividend Will Be Larger Than Last Year's
Jul 31Clorox: Stable Growth Prospects But Pricey
Jul 20Clorox (NYSE:CLX) Has A Pretty Healthy Balance Sheet
Jul 15Keeping My Portfolio Clean By Avoiding Clorox
Jul 06Colgate-Palmolive: Stagnation And Debt-Fueled Dividends
Jun 01Here's What's Concerning About Clorox's (NYSE:CLX) Returns On Capital
May 31Estimating The Fair Value Of The Clorox Company (NYSE:CLX)
Apr 25Clorox (NYSE:CLX) Has A Pretty Healthy Balance Sheet
Apr 07Clorox: Finally Emerging From The Pandemic Shadows
Feb 21Clorox declares $1.18 dividend
Feb 15The Clorox Company: Dividend Income Seekers Avoid Buying
Feb 09Be Wary Of Clorox (NYSE:CLX) And Its Returns On Capital
Feb 05Estimating The Intrinsic Value Of The Clorox Company (NYSE:CLX)
Jan 20Analyse CEO-vergoeding
| Datum | Totale vergoeding | Salaris | Bedrijfswinsten |
|---|---|---|---|
| Sep 30 2024 | n/a | n/a | US$357m |
| Jun 30 2024 | US$13m | US$1m | US$280m |
| Mar 31 2024 | n/a | n/a | US$240m |
| Dec 31 2023 | n/a | n/a | US$80m |
| Sep 30 2023 | n/a | n/a | US$86m |
| Jun 30 2023 | US$12m | US$1m | US$149m |
| Mar 31 2023 | n/a | n/a | US$74m |
| Dec 31 2022 | n/a | n/a | US$435m |
| Sep 30 2022 | n/a | n/a | US$405m |
| Jun 30 2022 | US$9m | US$1m | US$462m |
| Mar 31 2022 | n/a | n/a | US$458m |
| Dec 31 2021 | n/a | n/a | US$247m |
| Sep 30 2021 | n/a | n/a | US$437m |
| Jun 30 2021 | US$8m | US$1m | US$710m |
| Mar 31 2021 | n/a | n/a | US$923m |
| Dec 31 2020 | n/a | n/a | US$1b |
| Sep 30 2020 | n/a | n/a | US$1b |
| Jun 30 2020 | US$2m | US$524k | US$939m |
| Mar 31 2020 | n/a | n/a | US$870m |
| Dec 31 2019 | n/a | n/a | US$816m |
| Sep 30 2019 | n/a | n/a | US$813m |
| Jun 30 2019 | US$2m | US$436k | US$820m |
| Mar 31 2019 | n/a | n/a | US$796m |
| Dec 31 2018 | n/a | n/a | US$790m |
| Sep 30 2018 | n/a | n/a | US$841m |
| Jun 30 2018 | US$2m | US$436k | US$823m |
Compensatie versus markt: Linda's total compensation ($USD12.69M) is about average for companies of similar size in the US market ($USD12.87M).
Compensatie versus inkomsten: Linda's compensation has been consistent with company performance over the past year.
CEO
Linda Rendle (46 yo)
4.2yrs
Tenure
US$12,685,308
Compensatie
Ms. Linda Rendle serves as Chief Executive Officer and Director of The Clorox Company since September 14 2020 & serves as January 1, 2024. Ms. Rendle served as President of The Clorox Company from May 4, 2...
Leiderschapsteam
| Naam | Positie | Tenure | Compensatie | Eigendom |
|---|---|---|---|---|
| CEO & Chairman | 4.2yrs | US$12.69m | 0.014% $ 2.8m | |
| Executive VP & CFO | 6.6yrs | US$4.32m | 0.043% $ 8.8m | |
| Executive VP and Chief Operating & Strategy Officer | 4.2yrs | US$4.77m | 0.045% $ 9.0m | |
| Executive VP | 19.3yrs | US$3.45m | 0.0073% $ 1.5m | |
| Executive VP and Chief People & Corporate Affairs Officer | 8.7yrs | US$3.54m | 0.018% $ 3.6m | |
| VP, Chief Accounting Officer & Corporate Controller | 3.5yrs | geen gegevens | 0.0018% $ 355.3k | |
| Senior VP and Chief Information & Data Officer | 4.4yrs | geen gegevens | geen gegevens | |
| Vice President of Investor Relations | no data | geen gegevens | geen gegevens | |
| Senior VP & Chief Marketing Officer | 2.7yrs | geen gegevens | geen gegevens | |
| Chief Diversity Officer | 18.4yrs | geen gegevens | geen gegevens | |
| Executive VP and Executive Chief of Staff | 2.7yrs | US$3.56m | 0.0078% $ 1.6m | |
| Executive VP and Group President of Health & Hygiene | 3.2yrs | geen gegevens | 0.0084% $ 1.7m |
4.2yrs
Gemiddelde duur
52yo
Gemiddelde leeftijd
Ervaren management: CLX's management team is considered experienced (4.2 years average tenure).
Bestuursleden
| Naam | Positie | Tenure | Compensatie | Eigendom |
|---|---|---|---|---|
| CEO & Chairman | 4.2yrs | US$12.69m | 0.014% $ 2.8m | |
| Independent Director | 9.3yrs | US$287.50k | 0.0010% $ 212.0k | |
| Independent Director | 8.3yrs | US$267.50k | 0.00048% $ 96.9k | |
| Independent Director | 9.3yrs | US$292.50k | 0.00052% $ 105.0k | |
| Independent Director | 4yrs | US$267.50k | 0.00079% $ 159.5k | |
| Independent Director | 8.2yrs | US$267.50k | 0.00042% $ 84.8k | |
| Independent Director | 11.3yrs | US$282.50k | geen gegevens | |
| Lead Independent Director | 6.3yrs | US$405.00k | geen gegevens | |
| Independent Director | 4.5yrs | US$267.50k | geen gegevens | |
| Independent Director | 7.8yrs | US$267.50k | geen gegevens | |
| Independent Director | 2.5yrs | US$267.50k | geen gegevens | |
| Independent Director | 2.5yrs | US$267.50k | geen gegevens |
7.0yrs
Gemiddelde duur
61.5yo
Gemiddelde leeftijd
Ervaren bestuur: CLX's board of directors are considered experienced (7 years average tenure).